Skip to main content
Rhythm Pharmaceuticals, Inc. (RYTM)
NASDAQ: RYTM · Real-Time Price · USD
84.18
-1.02 (-1.20%)
Apr 28, 2026, 4:00 PM EDT - Market closed

Rhythm Pharmaceuticals Revenue

In the year 2025, Rhythm Pharmaceuticals had annual revenue of $189.76M with 45.83% growth. Rhythm Pharmaceuticals had revenue of $57.25M in the quarter ending December 31, 2025, with 36.87% growth.

Revenue (ttm)
$189.76M
Revenue Growth
+45.83%
P/S Ratio
30.29
Revenue / Employee
$458,350
Employees
414
Market Cap
5.75B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025189.76M59.63M45.83%
Dec 31, 2024130.13M52.70M68.06%
Dec 31, 202377.43M53.79M227.56%
Dec 31, 202223.64M20.48M649.46%
Dec 31, 20213.15M--
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
PTC Therapeutics 1.73B
Caris Life Sciences 812.03M
Mirum Pharmaceuticals 521.31M
Centessa Pharmaceuticals 15.00M
CG Oncology 4.04M
Revenue Rankings

RYTM News

More News